Açık Akademik Arşiv Sistemi

Safely use of omalizumab during SARS-CoV-2 infection in patients with chronic spontaneous urticaria

Show simple item record

dc.date.accessioned 2023-03-06T07:32:38Z
dc.date.available 2023-03-06T07:32:38Z
dc.date.issued 2023
dc.identifier.citation J Cosmet Dermatol. 2023 Jan;22(1):26-27. doi: 10.1111/jocd.15544. Epub 2022 Nov 30.
dc.identifier.uri https://hdl.handle.net/20.500.12619/100394
dc.relation.isversionof 10.1111/jocd.15544
dc.relation.isversionof 10.1111/jocd.15544
dc.title Safely use of omalizumab during SARS-CoV-2 infection in patients with chronic spontaneous urticaria
dc.relation.journal J Cosmet Dermatol
dc.identifier.doi 10.1111/jocd.15544
dc.contributor.author Özdemir Ö
dc.contributor.author Özdemir Ö
dc.contributor.author Dikici Ü.


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record